Texas Bank & Trust Co purchased a new stake in Xylem Inc. (NYSE:XYL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,650 shares of the industrial products company's stock, valued at approximately $307,000.
Other hedge funds have also recently bought and sold shares of the company. Lee Danner & Bass Inc. purchased a new position in shares of Xylem during the 4th quarter valued at approximately $30,000. Rialto Wealth Management LLC bought a new position in Xylem during the 4th quarter valued at $31,000. Heck Capital Advisors LLC bought a new position in Xylem during the 4th quarter valued at $36,000. Pathway Financial Advisers LLC grew its holdings in Xylem by 122.4% during the 4th quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock worth $37,000 after acquiring an additional 175 shares in the last quarter. Finally, SRS Capital Advisors Inc. increased its position in shares of Xylem by 69.5% in the 4th quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock worth $37,000 after purchasing an additional 130 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.
Xylem Stock Performance
NYSE:XYL traded down $0.47 during midday trading on Thursday, reaching $125.19. 1,383,608 shares of the company traded hands, compared to its average volume of 1,416,158. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.89. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.76 and a quick ratio of 1.33. The company has a fifty day moving average price of $117.46 and a 200 day moving average price of $121.48. The firm has a market capitalization of $30.47 billion, a price-to-earnings ratio of 34.21, a price-to-earnings-growth ratio of 2.33 and a beta of 1.10.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.08. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.04 billion. During the same period last year, the firm posted $0.90 EPS. Xylem's quarterly revenue was up 1.8% compared to the same quarter last year. On average, analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, May 29th. This represents a $1.60 annualized dividend and a dividend yield of 1.28%. Xylem's dividend payout ratio is presently 43.01%.
Analyst Ratings Changes
XYL has been the topic of several research analyst reports. Citigroup reduced their price target on shares of Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Raymond James raised Xylem to a "hold" rating in a report on Thursday, May 15th. Royal Bank of Canada boosted their price target on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. Stifel Nicolaus upped their price target on Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a research report on Wednesday, April 30th. Finally, Robert W. Baird decreased their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $146.88.
Get Our Latest Research Report on Xylem
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.